By the time a new medical product earns regulatory approval and enters post-marketing clinical trials, their eClinical needs change. Phase IV clinical trials are big, involving a large number of patients and data over a longer timeframe, while still employing a relatively simple and straightforward design compared to the more intricate studies of Phase III. Medrio’s popularity in Phase IV derives from the rare ability to cater to both of these aspects simultaneously.
Here’s what that means.
While Phase IV clinical trial design is often relatively straightforward, these studies still involve lots of patients and, therefore, lots of sites and data over a longer timeframe. Phase IV researchers need a stable and robust system that can accommodate these large datasets and optimize collaboration. Medrio users have found the system adept at handling large quantities of data while still running smoothly. And as a secure cloud-based EDC, Medrio empowers users to share data and perform monitoring tasks much more easily than they could with an on-premise solution.